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Abstract
Inherited bleeding disorders including abnormalities of platelet number and function rarely
occur in a variety of dog breeds, but are probably underdiagnosed. Genetically character-
ized canine forms of platelet disorders provide valuable large animal models for under-
standing similar platelet disorders in people. Breed-specific disease associated genetic
variants in only eight different genes are known to cause intrinsic platelet disorders in dogs.
However, the causative genetic variant in many dog breeds has until now remained
unknown. Four cases of a mild to severe bleeding disorder in Cocker Spaniel dogs are
herein presented. The affected dogs showed a platelet adhesion defect characterized by
macrothrombocytopenia with variable platelet counts resembling human Bernard-Soulier
syndrome (BSS). Furthermore, the lack of functional GPIb-IX-V was demonstrated by
immunocytochemistry. Whole genome sequencing of one affected dog and visual inspec-
tion of the candidate genes identified a deletion in the glycoprotein IX platelet (GP9) gene.
The GP9 gene encodes a subunit of a platelet surface membrane glycoprotein complex;
this functions as a receptor for von Willebrand factor, which initiates the maintenance of
hemostasis after injury. Variants in human GP9 are associated with Bernard-Soulier syn-
drome, type C. The deletion spanned 2460 bp, and included a significant part of the single
coding exon of the canine GP9 gene on dog chromosome 20. The variant results in a
frameshift and premature stop codon which is predicted to truncate almost two-thirds of
the encoded protein. PCR-based genotyping confirmed recessive inheritance. The
homozygous variant genotype seen in affected dogs did not occur in 98 control Cocker
Spaniels. Thus, it was concluded that the structural variant identified in the GP9 gene was
most likely causative for the BSS-phenotype in the dogs examined. These findings provide
the first large animal GP9 model for this group of inherited platelet disorders and greatly
facilitate the diagnosis and identification of affected and/or normal carriers in Cocker
Spaniels.
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Introduction
Sporadic cases of a severe bleeding disorder characterized by dysfunctional platelets could be
explained by rare forms of inherited thrombocytopathies [1]. This group of haemorrhagic dis-
orders show a marked phenotypic heterogeneity classified according to platelet function into
adhesion, activation, secretion, and aggregation defects [2]. The two best characterized platelet
adhesion defects in humans are Glanzmann thrombasthenia (GT, OMIM 273800) and Ber-
nard-Soulier syndrome (BSS, OMIM 231200) [3,4]. Human BSS is a rarely reported hereditary
bleeding disorder initially described by Bernard and Soulier in 1948 in a young man with a
prolonged bleeding time, mild thrombocytopenia and giant platelets approaching the size of
lymphocytes caused by a defect of the platelets lineage [5,6]. BSS often presents early with
bleeding symptoms, such as epistaxis, ecchymosis, menometrorrhagia, and gingival, gastroin-
testinal, muscular or visceral bleeding. BSS is caused by a defect in or deficiency of the platelet
membrane von Willebrand factor (vWF) receptor complex, glycoprotein Ib-IX-V (GPIb-
IX-V) [7]. At sites of vascular injury, the GPIbα component of this receptor binds the adhesive
protein, vWF, to support platelet adhesion and platelet thrombus formation. Since GPIb-IX-V
is composed of four subunits encoded by four separate genes, glycoprotein Ib platelet alpha
subunit (GP1BA), glycoprotein Ib platelet beta subunit (GP1BB), glycoprotein IX platelet
(GP9), and glycoprotein V platelet (GP5), the molecular basis of BSS is characterized by locus
and allelic heterogeneity [8], although, until today no disease causing the GP5 variant has been
identified.
Moreover, various forms of inherited platelet disorders have been reported in dogs at the
functional, biochemical, and molecular levels [9]. Currently, the Online Mendelian Inheri-
tance in Animals (OMIA) [10] catalogue reports three genetically characterized canine forms
of Von Willebrand disease (OMIA 001057-9615, OMIA 001339-9615; OMIA 001058-9615),
corresponding to the most common hereditary extrinsic platelet disorder in humans in which
the platelets are normal but a large multimeric glycoprotein necessary for their function is
either absent, reduced, or dysfunctional (OMIM 613160). On the other hand, intrinsic platelet
disorders also occur sporadically in dogs and, involve the platelets directly arising from abnor-
malities in platelet granules, membrane glycoproteins, signal transduction proteins, or pro-
teins involved in platelet production from megakaryocytes [9]. Currently, OMIA lists the
following causative breed-specific genetic variants of eight different canine intrinsic platelet
disorders: ITGA2B-associated forms of thrombasthenia in Great Pyrenees and Otterhounds
corresponding to human GT (OMIA 001000-9615), the AP3B1-associated platelet storage
pool defect in Grey Collies (OMIA 000248-9615), RASGRP1-associated platelet aggregation
defects in Basset hounds, Eskimo Spitz and Landseers (OMIA 001003-9615), P2RY12-associ-
ated platelet aggregation defect in Greater Swiss Mountain dogs (OMIA 001564-9615),
FERMT3-associated leukocyte adhesion deficiency in German Shepherds (OMIA 001525-
9615), TUBB1-associated macrothrombocytopenia in Cavalier King Charles Spaniels and nine
other dog breeds (OMIA 001001-9615), MYH9-associated giant platelet disorders in Pugs
(OMIA 001608-9615), and ANO6-associated platelet activation defect in German Shepherds
(OMIA 001353-9615). However, the list of canine bleeding defects in which the molecular eti-
ology was not investigated is still long and includes not only predominantly extrinsic platelet
disorders (OMIA 001056-9615) but also rare forms of intrinsic platelet disorders such as the
inherited platelet delta-storage pool disease described in Cocker Spaniel (CS) dogs (OMIA
001198-9615).
In the present study, three independent Cocker Spaniels of Italian origin and a fourth dog
of Czech origin, which all showed characteristic signs of human BSS, were investigated. An
earlier report described a similar platelet disorder in five Cocker Spaniels of American origin
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[11], but the molecular etiology was not investigated in any of these cases. The aim of the pres-
ent study was to identify the causative genetic variant for the phenotype in the affected Cocker
Spaniel of European origin.
Materials and methods
Ethics statement
This study did not require official or institutional ethical approval as it was not experimental.
The animals were handled according to good ethical standards and Italian legislation. The
dogs in this study were examined with the written consent of their owners. The aim was to
identify the cause of the congenital disorder and thereby improve the animal welfare situation
of the breed.
Brief clinical description of cases
Proband BSS#1 was represented by a three year-old CS male dog visited by the practitioner
due to a prolonged episode of bilateral epistaxis. The dog underwent rhinoscopy with unre-
warding findings and was then referred to the Veterinary Hospital. The owner did not report
any previous history of hemorrhagic diathesis. At admission, the presenting complete blood
count (CBC) values were indicative of a mild thrombocytopenia (56 x 103 /μL; reference range
160–500 /μL) with a majority of giant platelets. The Mean Platelet Volume (MPV) was 27.3 fL
(ADVIA 2120, Siemens; reference value 8.7–15.0 fL). The hematocrit (Hct) (37.3%) was within
the reference range (37.0–55.0%). The dog was maintained under general anesthesia and
underwent supportive therapy (S1 Fig). Despite the therapy, the overall conditions worsened
with the onset of hematuria and melena and a dramatic drop in Hct. The dog was transfused
with whole blood twices and immunosuppressive therapy was instituted until the clinical signs
gradually resolved, within 10 days. Months after the bleeding episode, the dog underwent
another CBC as a control. Despite an apparent healthy condition, the CBC continued to show
alterations inconsistent with ongoing immune-mediated thrombocytopenia (IMT). After the
above-described episode, no other severe bleeding episode occurred in the next 3 years, and
the only complaint of the referring practitioners was a mild but continuing delay in clot forma-
tion after venipuncture with the tendency of hematoma formation at the venipuncture site.
Proband BSS#2 was a two year-old male CS which was referred for a mild but persistent
bleeding episode after neutering. The CBC showed macrothrombocytopenia. The macrotrom-
bocytopenia persisted after resolution of the clinical signs with fluctuating platelet values in the
20K–60K range.
Proband BSS#3 was represented by a three-year-old male CS with periodic and self-limiting
episodes of gingival bleeding associated with macrothrombocytopenia unresponsive to corti-
costeroid drugs.
Proband BSS#4 was a female CS of Czech lineage which had a history of a few cases of
bleeding problems. The dog had recurrent mild to moderate bleeding problems including
gingival bleeding, hematuria and vulvar bleeding after mating. In addition to BSS#4 in this
pedigree, another relative bitch died of severe bleeding episode after delivery and despite trans-
fusion and symptomatic therapy.
Phenotypic characterization
Complete blood count and platelet analysis. The analysis of the platelet morphology was
carried out using the ADVIA 2120 Hematology System (Siemens) in two (BSS#1 and BSS#3)
out of the four probands and in the heterozygous relatives of BSS#1 (Fig 1).
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This analyzer uses recent improvements in automated blood cell count and allows measure-
ment of several platelet parameters, providing additional information regarding on the under-
lying mechanisms of thrombocytosis and thrombocytopenia. The platelets are scattered in a
two-dimensional analysis based on the integration of a two-angle laser light scattering flow-
cytometric method. By measuring the light scatter at a low angle scatter at 2–3˚ for volume
assessment and a high angle scatter at 5–15˚ as refractive index, this instrument measures the
following platelet parameters: platelet distribution width (PDW), platelet crit (PCT), mean
platelet component (MPC), mean platelet mass (MPM), and large platelet count (LPLT;
volume > 20fL), in addition to the total platelet count (PLT) and mean platelet volume
(MPV). However, except for the PLT and MPV, these parameters are not routinely reported or
widely used in clinical practice, and only limited information is available regarding dogs
[12,13].
Western blot analysis. The dog platelets were lysed in sodium dodecyl sulfate (SDS) solu-
tion (Tris–HCl 50 mM pH 6.8; SDS 2%; glycerol 5%) supplemented with a cocktail of protease
inhibitors (Sigma-Aldrich Co. LLC). The total protein contents were determined by the Lowry
method using a protein assay kit (Sigma-Aldrich Co. LLC). Aliquots containing 10 μg of total
proteins were separated using NuPage 4–12% bis-Tris Gel (Gibco-Life-Technologies) for 50
min at 200 V. The proteins were then electrophoretically transferred onto a nitrocellulose
membrane using the Turbo Blot System (Bio-Rad). The blot was washed in PBS and protein
transfer was checked by staining the nitro-cellulose membrane with 0.2% Ponceau Red and
the gels with Comassie Blue. Non-specific binding on the nitrocellulose membranes was
blocked with 5% milk powder in Phosphate Buffer Saline-0.1% Tween-20) (PBS-T20) for 1 h
at room temperature. The membrane was then incubated over-night at 4˚C with a 1:500 dilu-
tion of the primary monoclonal antibody mouse anti-CD42a (clone FMC-25, cod. MA5-
16684, Thermo Fisher Scientific, Rockford, IL, USA). After several washings with PBS-T20,
the membrane was incubated with the secondary biotin-conjugate antibody and then with a
1:1000 dilution of an anti-biotin horseradish peroxidase (HRP)-linked antibody.
The western blot was developed using a chemiluminescent substrate (Super Signal West
Pico Chemiluminescent Substrate, Pierce Biotechnology, Inc, Rockford, IL, USA) according to
Fig 1. Pedigree chart of the proband BSS#1. Squares and circles denote males and females, respectively. The parents
are connected by a horizontal line and a vertical line leads to their offspring. The filled symbol denotes an affected dog.
The clear symbol denotes a healthy dog. The genotype of each dog is reported below the square or circle. WT: Wild-
type allele; “-”: variant allele. The proband is indicated by an arrowhead.
https://doi.org/10.1371/journal.pone.0220625.g001
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the manufacturer’s instructions. The intensity of the luminescent signal of the resultant bands
was acquired by Chemi Doc using Quantity One Software (Bio-Rad).
In order to normalize the CD42a data regarding the housekeeping protein, the membrane
was stripped (briefly: the membrane was washed 5 min in water, 5 min in 0.2 M sodium
hydroxide and then washed again in water) and re-probed for housekeeping β-tubulin (1:500
of anti β-tubulin sc-9104, Santa Cruz Biotechnology, USA). The relative protein content
(cd42a/tubulin) was expressed as arbitrary units (AUs).
Immunocytochemistry. Blood samples in citrated tubes (Vacutest, KIMA, Italy) each
containing 3.5 mL anticoagulated blood were collected from one of the authors (FG) as a posi-
tive control for the primary antibody, from one healthy dog (interspecies positive control) and
from the BSS#1 affected dog. The blood tubes were centrifuged at 800 x g for 8 min at 4˚C and
the supernatant platelet rich plasma (PRP) was collected and transferred into 15 mL plastic
tubes, and the platelets were counted. The PRP was then centrifuged again at 2000 x g for 5
min at 4˚C. The supernatant was eliminated and the platelet pellet was gently resuspended in
1mL of PBS pH7.4, counted again and diluted using PBS pH7.4, it was counted at a final con-
centration of 1 x 103 cells/μL. Two quantities of 10 and 100 uL of platelet resuspension were
then immobilized on polylysinated slides by centrifuging for 10 minutes at 500 x g using a
cytospin chamber in an Ettich centrifuge. Finally. the cytological smears were immediately fro-
zen at -80˚C and stored until use. The slides were hydrated in PBS and were processed for
immunostaining. To block non-specific bindings, the sections were incubated in a solution
containing 20% normal donkey serum (cod. 1700121, Jackson ImmunoResearch Laboratories,
Inc, West Grove, PA, USA), 1% bovine serum albumin (cod. A-9418, Sigma Aldrich, Milan,
Italy, Europe) in PBS for 1 h at RT. The slides were incubated overnight in a humid chamber
at RT with the primary monoclonal antibody mouse anti-CD42a (clone FMC-25, cod. MA5-
16684, Thermo Fisher Scientific, Rockford, IL, USA) diluted 1:200 in 1.8% sodium chloride
(NaCl) in 0.01M PBS containing 0.1% sodium azide. After washing in PBS (3 x 10 min), the
slices were incubated for 1 h at RT in a humid chamber with the secondary antibody goat anti-
rabbit immunoglobulin G (IgG) fluorescein isothiocyanate conjugated (cod.401314; Merck
Millipore, Darmstadt, Germany, Europe) diluted 1:200 in PBS. The same experiment was car-
ried out permeabilizing the cell membranes by adding 1% Triton-X100 (cod. T8787, Sigma
Aldrich, Milan, Italy, Europe). The slides were then washed in PBS (3 x 10 min) and mounted
in buffered glycerol at pH 8.6 with 4’,6-diamidino-2-phenylindole—DAPI- (Santa Cruz Bio-
technology, CA, USA).
The slides were examined using a Nikon Eclipse Ni microscope equipped with the appro-
priate filter cubes to distinguish the fluorochromes employed. The images were recorded with
a Nikon DS-Qi1Nc digital camera and NIS Elements software BR 4.20.01 (Nikon Instruments
Europe BV, Amsterdam, Netherlands). Slight adjustments to contrast and brightness were
made using Corel Photo Paint whereas the figure panels were prepared using Corel Draw
(Corel Photo Paint and Corel Draw, Ottawa, ON, Canada).
Whole genome sequencing, variant calling. For the resequencing of one of the affected
dogs, a PCR-free genomic fragment library with 350 bp insert size was prepared which, and
collected roughly 28× coverage data on an Illumina HiSeq3000 instrument (2 × 150 bp). Read
mapping, aligning and variant calling and filtering were carried out as previously described
[14]. Functional candidate genes were visually inspected for structural variants using the BAM
file from the affected dog and the Integrative Genomics Viewer [15].
Reference sequences. All the genetic analyses were carried out with respect to the
CanFam 3.1 genome reference assembly and the NCBI Canis lupus familiaris annotation
release 105. Numbering within the canine GP9 gene refers to the mRNA accession number
XM_846924.5 [16] and the protein accession number XP_852017.1 [17].
Bernard-Soulier syndrome in Cocker Spaniel dogs
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Genetic testing and epidemiological survey. To ascertain the allele frequency in the CS
population, an assay for the rapid detection of the deletion was established. To that aim,
genetic testing was carried out using a multiplex end-point PCR. To that end, PCR was carried
out using a mixture composed of 3 μL of 5× PCR buffer (Phusion GC Green buffer), 200 μM
each dNTPs, 600 nM GP9_F1 primer (TAAGTGTGAAGCCGGTGAGC), 600 nM GP9_R1
(TACATCACGGCCACTGTCTC) primer, 400 nM GP9_F3 primer (CAGCCAGAGACGCAGGT
AG), 0.3 u/reaction of Phusion Polymerase (Thermo Scientific), 2 μL of template, and molecu-
lar biology–grade water to reach a final volume of 15 μL. The PCR was carried out using a
3-step protocol: initial denaturation at 98˚C for 30 s followed by 40 cycles at 98˚C for 10 s,
63˚C for 15 s, 72˚C for an additional 15 s. The variant allele originates a band which is 601 bp
long whereas the wild type allele originates a 339 bp band. (Fig 2).
Overall, ninety-eight gDNA samples of cocker spaniels were genotyped for the BSS variant.
The gDNA was retrieved from two genetic testing laboratories (46 from Italy and 20 from
Switzerland) and it was purified from additional thirty-two frozen blood samples harvested
from CS examined for medical reasons at the Veterinary Teaching Hospital and which had
been stored frozen in the laboratory hospital repository.
Results and discussion
Clinical manifestations
Clinical signs of diseases in the cases described herein overlapped those described in humans.
Individual variation was remarkable. Bleeding tendencies were almost invariably present but
were frequently overlooked. The most common sign indicating bleeding tendency was the
hematoma formation after venipuncture reported by the referring practitioners; this occurred
despite the careful and prolonged compression of the site after venipuncture which had been
Fig 2. Genetic test assay. A) Schematic representation of the genetic testing assay; the common reverse primer
GP9_R1 together with two different forward primers, GP9_F1 aligning in the conserved region upstream the GP9
coding sequence and GP9_F3 aligning in the 2.5 kb deleted sequence are used to amplify in a multiplexed polymerase
chain reaction assay the GP9 locus. B) A representative examples of the results of the genotyping assay showing the 601
bp long and the 339 bp band long bands indicating the mutated and wild type alleles, respectively.
https://doi.org/10.1371/journal.pone.0220625.g002
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recommended in those dogs receiving the diagnosis. Episodic and self-limiting gingival bleed-
ing were also frequently reported. Subtle signs of bleeding tendencies were overlooked until a
trauma had exacerbated an overt hemorrhage. In the cases in the present study, trauma was
minimal and had occurred during intense outdoor activity, nasal cavity endoscopic explora-
tion following an episode of blood streaked nasal discharge or after mating. In addition, deliv-
ery was reported to be a likely inciting cause of uncontrolled bleeding. Bleeding was already
evident in young dogs but not in puppies. The age at presentation for the first evidence of a
bleeding problem was 2–4 years. In humans, bleeding tendencies associated with BSS are usu-
ally evident from early childhood. However, the severity of symptoms may progressively
worsen or ease throughout puberty and adult life according to different variants [6]. The cases
in the present study had been monitored for a few years. No conclusion could be drawn to sup-
port a worsening of bleeding signs over time. Instead, the signs seemed to be stable and the
dogs continued to experience a good quality of life. Also, in the case series reported here, the
majority of dogs were male. However, no gender predisposition is reported in human medi-
cine and only the increased mortality risk associated with surgery in women is reported [18].
The owners have to be warned that their dogs will suffer bleeding tendencies throughout
their entire life and that the only recommended therapy in case of severe hemorrhage is whole
blood or platelet rich plasma from a fully compatible dog. Since it is likely that transfusion will
have to be repeated during the lifetime of the dogs, the blood group typing of both the donor
and the affected dog was imperative. The use of DDAVP (1-deamino-8-D-arginine vasopres-
sin) has been reported to improve the clinical signs and to shorten the time of bleeding in
some human patients [19–22]. The underlying mechanism is still unknown but it might be
related to an increase in factor FVIII levels induced by DDAVP infusion [23]. Another recom-
mendation is to cautiously use drugs having an inhibitory effect on platelet aggregation, such
as aspirin or, more generally, non-steroid anti-inflammatory drugs. Clearly, immunosuppres-
sive therapy for IMT is detrimental and should be avoided.
In humans, BSS is characterized by a bleeding tendency, circulating giant platelets in the
blood and variably low platelet counts. Clinical manifestations usually include purpura, epi-
staxis, menorrhagia, and gingival and gastrointestinal bleeding. In humans, the diagnosis is
based on a prolonged skin bleeding time, the presence of a small number of very large platelets
(macrothrombocytopenia), defective ristocetin-induced platelet agglutination and/or low or
absent expression of the GPIb-V-IX complex as evidenced by flow cytometry. Prothrombin
consumption is markedly reduced. However, the disease is listed among a group of disorders
of platelets with overlapping clinical pictures. For these orphan (rare) diseases the diagnosis is
very challenging and frequently delayed or even completely missed in particular in developing
countries [24,25]. To overcome this drawback, third level referral centers may use refined diag-
nostic protocols which include combination of basic methods, such as platelet morphology
and immunofluorescence carried out directly on a blood smear with available genetic testing
to diagnose hereditary platelet disorders. The prognosis is usually good with adequate support-
ive care but severe bleeding episodes can occur with trauma and surgical procedures especially
in those subjects in which a diagnosis has not yet been established. Treatment of bleeding or
prophylaxis during surgical procedures usually requires platelet transfusion, desmopressin and
antifibrinolytics [18].
CBC phenotype
The platelets of the proband dogs BSS#1 and BSS#3 were characterized using platelet indices
measured by the ADVIA 2120. Both dogs presented macrothrombocytopenia with variable
platelet counts over time even in the same subjects (Table 1).
Bernard-Soulier syndrome in Cocker Spaniel dogs
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Almost half of the platelets were markedly large as observed on May Gru¨nwald-Giemsa
(MGG) stained smears, even approximating the red blood cell (RBC) volume (Fig 3).
In humans, a mean platelet diameter > 3.7 μm is considered the cutoff of “giant platelets”
typical of Bernard-Soulier syndrome and MYH9 disorders. Similarly, the size of “giant plate-
lets” in dogs was between half and one RBC in diameter (6–8 μm) [26]. The presence of
“giant” platelets was confirmed by an elevated count of “large platelets” having a volume >
20fL. From 47 to 67% of the total count were large platelets (Table 1). Although half of the
platelets were larger than normal, the platelet distribution width (PDW) index, which mirrors
the variability of platelet size, was lower than normal (Table 1). In fact, the PDW histograms of
the affected dogs indicated that the platelets aggregated in 2 clusters with low and high volume,
respectively with a pattern different from the typical anisocytosis seen with a high PDW.
In humans, it has been reported that platelets concentrations fluctuate widely [6] over time
between marginally low (30000/μL) to normal values even in the same subject. The probands
herein described presented PLT values which were always below the threshold of the reference
range. However, the plateletcrit may occasionally fall within the reference range (Table 1)
since the whole platelet mass takes into account the low number but also the higher than nor-
mal volume of platelets.
The giant platelet granular density appeared quite normal and no cytoplasmic projection of
pseudopods indicating activation could be seen (Fig 3). This was additionally confirmed by the
higher than normal mean platelet component (MPC) which is a measurement of the mean
refractive index. The MPC indicates platelet density, and decreases after activation and subse-
quent degranulation. In dogs, the MPC has been shown to decrease during long storage activa-
tion [13].
In veterinary medicine, very little information is present in the literature regarding the
platelet indices in dogs. Platelet indices have been evaluated in endotoxiemia [27], IMT [28],
babesiosis [29], and sample storage [13], and in healthy dogs for reference range establishment
[12].
Table 1. Platelet indices measured by ADVIA 2120.
BSS#1 dog Heterozygous relatives; n = 4 BSS#3 dog Reference population; n = 1928 ADVIA 2120
Canine Reference interval §median range median range median 5th–95th percentiles
PLT
(103 cells/μL)
56.00 42.00–125.00 321.50 240.00–340.00 49.00 325.00 108.05–689.95 173.0–486.0
PCT(%) 0.16 0.13–0.37 0.36 0.30–0.42 0.11 0,40 0.05–1.23 0.3–0.5
MPV(fL) 27.50 24.10–30.90 12.15 9.70–13.90 24.20 12,5 9.0–19.2 8.56–14.41
Large PLT
(103 cells/μL)
33.00 28.00–81.00 23.50 12,00–33,00 26.00 35.5 7.0–113.7 6.64–84.23
PDW(%) 52.95 49.40–61.70 62.35 57.70–65.20 58.90 64,7 52.84–73.07 55.7–66.9
MPC(g/dL) 21.25 20.60–24.00 22.20 22.00–25.00 21.80 20,9 17.4–24.2 14.0–18.6
PCDW(g/dL) 6.85 4.40–7.90 4.60 4,30–5,70 8.00 6.8 3.9–8.3 4.58–7.05
MPM(pg) 4.02 3.64–4.13 2.45 2,26–2,64 3.05 2.2 1.8–3.0 1.32–1.92
PMDW(pg) 1.11 0.91–1.61 0.98 0,88–1,07 1.22 0.9 0.7–1.3 0.51–0.84
PLT: platelet count; PCT: thrombocrit; MPV: mean platelet volume; Large platelet: count of platelets with a volume > 20fL; PDW: platelet distribution width; MPC:
mean platelet component concentration; PCDW: mean platelet component distribution width: MPM: mean platelet mass; PMDW: mean platelet mass distribution
width.
§ Moritz et al., 2004
https://doi.org/10.1371/journal.pone.0220625.t001
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Based on the platelet indices measured in the probands, a step-by-step algorithm was
implemented (S2 Fig) and used to search for other possible hereditary macrothrombocytope-
nias in the CBC archive of the Veterinary Teaching Hospital of the University of Bologna over
a one-year period. Of the 1940 CBCs analyzed over the course of one year and excluding the
CBCs of the BSS#1 affected dog, only eight cases were selected by the algorithm, five being
Cavalier King Charles Spaniel dogs, a hemolytic mongrel dog affected by pyometra, a case of
Ehrlichiosis and a case of immune-mediated hemolytic anemia and IMT. The data from a
more numerous group of affected dogs could certainly have refined the thresholds and the
overall usefulness of an algorithm based on platelet indices. Furthermore, the algorithm may
be helpful in differentiatinmg hereditary macrothrombocytopenias from acquired ones.
Molecular basis
Based upon the evaluation of PLT indices and the morphology of those subjects included in
the pedigree of proband BSS#1, the heterozygous relatives (Fig 2) did not show any differences
in any parameter with respect to the reference population [30]. Hence, it is very likely that the
disease shows an autosomic recessive inheritance pattern. In humans, almost all the cases
reported alsos1 show an autosomal recessive inheritance, and only a few families having
Fig 3. Platelets morphology in a Bernard-Soulier syndrome affected dog. Light microscopy of May Gru¨nwald-Giemsa stained smears of
the BSS#1 affected dog at 100 X (A); 400 X (B) and 1000 X (C,D) magnification. Black arrowheads indicate “giant platelets” in comparison to
normal platelets (grey arrowhead).
https://doi.org/10.1371/journal.pone.0220625.g003
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autosomal dominant forms with variants in the GP1Bα gene [31,32] or GP1Bβ have been
described [33].
The proband BSS#1 showed the lack of the GPIb-V-IX complex on the platelet cell mem-
brane. In platelets from the healthy human volunteer and the healthy dog (positive controls),
CD42a was strongly expressed on the cell membrane while, in the BSS#1, no signal was
detected, demonstrating the lack of CD42a assembled in the GPIb-V-IX complex at the platelet
membrane (Fig 4).
The lack of functional GPIb-IX-V on the platelet membrane is the hallmark of all the BSS
variants reported in humans, and results in impaired binding to vWF and a dramatically
reduced ability to adhere to the subendothelium of a damaged vascular wall or to agglutinate
in response to ristocetin. Furthermore, there is the absence of other binding sites for P-selectin,
thrombospondin-1, factor VIIa, factor XI, factor XII, aMb2, and high molecular weight kini-
nogen. While the majority of the functional domains and the binding sites for vWF and
thrombin are on GP1bα, both GP1bβ and GPIX are necessary for the adequate trafficking of
the GPIb-V-IX complex and its expression on the cell membrane by hampering its degrada-
tion [34,35].
Whole genome sequencing of one affected dog and subsequent automated variant filtering
based on a monogenic autosomal recessive mode of inheritance with respect to 188 non-
affected control dogs of different breeds and three wolves, revealed 1927 homozygous variants
private to the affected dog. None of these variants was located within a candidate gene. Given
Fig 4. Platelet immunocytochemistry. Photomicrographs showing CD42a immunoreactivity. In human (A) and in
healthy dog (control) platelet samples (B), a strong signal was evident on the cell membranes. In the sample from the
BSS#1 affected dog (C), no signal was detected. Under permeabilization conditions (Triton X100), the pathological
sample shows an intracellular signal (filled arrows) (D). Scale bars = 50 um.
https://doi.org/10.1371/journal.pone.0220625.g004
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that the automated pipeline did not detect any private protein changing variants affecting a
gene known for a platelet disorder, it was hypothesized that a larger structural variant might be
causative for the disorder. Structural variants, such as large insertions, deletions, duplications,
or inversions would be missed by the applied variant detection software. Therefore, all four
known genes (GP1BA, GP1BB, GP5, and GP9) involved in human BSS were selected as func-
tional candidate genes, and they were visually inspected for structural variants.
In the chromosomal region of the GP9 gene, a large structural variant was detected in
homozygous state in the genome of the affected dog (Fig 5).
The formal variant designation is chr20:3,025,814_3,028,273del2460. The deletion truncates
104 (71%) of the 146 codons of the wildtype canine reading frame. No structural variants
affecting the coding regions of the other candidate genes were detected.
The lack of the GPIb-V-IX complex in the BSS cases herein described in Cocker Spaniel
dogs was most likely caused by a large 2460 bp deletion, spanning almost half of GP9 exon 2.
Exon 2 is the only coding exon of the GP9 gene, which also encompasses a small leading exon
1. Variants on GP9, such as homozygous [36] or compound heterozygous with other GP9 or
GP1BB and GP1BA gene have been reported in humans.
To confirm the presence of the deletion, a PCR approach was chosen. Two primers flanking
the large deletion were designed as well as one primer inside the deletion, and a PCR was car-
ried out using these three primers. In the affected dogs, a single PCR product resulted and, for
the heterozygous relatives two PCR products resulted, which was consistent with the expected
fragment sizes (Fig 2).
Despite the deletion of the C-terminus, the GPIX was detected with WB in platelet lysates
at an approximate 50% level of expression in comparison to dogs carrying wild-type alleles in
homozygousity (S3 Fig); even so, the deleted protein was expressed but was not localized with
the other proteins on the cell surface as GPIb-V-IX complex. In fact, using the same monoclo-
nal antibody as in WB and permeabilization with Triton X-100 added to the solutions,
Fig 5. Large genomic deletion spanning the coding exon of the canine GP9 gene in the BSS-affected dog.
https://doi.org/10.1371/journal.pone.0220625.g005
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immunostaining of naïve platelets of the affected dog revealed a weak signal of CD42a with a
patchy pattern consisting of intracellular aggregates and a faint signal from the membrane. In
human BSS variants, variants occurring in GPIX prevent the expression of the complex at the
cell surface, markedly reducing the overall protein expression, which may accumulate in the
endoplasmic reticulum and (ER) and ER-associated Golgi [34,37]. The vast majority of GPIX
variants which have been reported until now are missense [8] while GPIX protein truncation
determined by frameshift (insertions, duplication/ small deletions) or nonsense variants have
been reported very rarely [38–41]. In one case, N-terminal truncated GPIX protein expression
was almost completely absent on cell membrane and also intracellularly [40]; in other cases,
the affected platelets were only investigated using flow cytometry, and assumptions on the
intracellular localization and accumulation could not be drawn. In the present study, the dele-
tion may have bridged the remaining 5’ part of coding exon 2 with sequences downstream
exon. In silico evaluation showed that the novel stop codon may occur after that 58 novel aa
are included in translation. The variant protein would be 144 aa long instead of 177. The theo-
retical molecular weight (MW) of the two aa chains differ of three Kda. This small MW differ-
ence may explain why WB found an apparently specific band also in the affected dog.
WB analysis showed a band corresponding to CD42a in both the wild type and variant sam-
ples, however the intensity was significantly reduced in pathological sample which in turn
appeared slightly shifted downward.
Allele prevalence
Based on the findings of the genetic survey the prevalence of the variant allele was 4.6% with a
distribution of genotypes frequencies of 91.8% of homozygous wild-type, 7.1% of heterozygous
and 1% of homozygous variant. The genotype frequencies were consistent with the Hardy-
Weinberg equilibrium (chi-squared = 3.35; p = 0.07).
Conclusions
In conclusion, a novel hereditary bleeding disorder affecting Cocker spaniel dogs and the
responsible variant thereof has herein been described for the first time. The disease is the
orthologue of BSS described in humans and could represent a valid animal model of spontane-
ous disease. To date, BSS has never been reported in dogs nor in any other domestic animals.
Recently, the International Mouse Phenotyping Consortium reported that the knockout of
Gp9 in mice caused thrombocytopenia with increased platelet volume [42].
Furthermore, the genetic test could support the diagnosis in those dogs with bleeding ten-
dencies or ongoing thrombocytopenia in addition to an ancillary test of clinical pathology,
such as light microscopy, CBC including PLT indices, immunofluorescence and/or cytometry.
For those dogs, having a diagnosis of BSS, appropriate support in terms of genetic counselling
would be warranted in order to guarantee an adequate quality of life and life expectancy.
Finally, a genetic test could easily identify carrier dogs and be introduced as a marker assisted
breeding programs/genetic counselling.
Supporting information
S1 Fig. Bleeding in BSS#1 affected Cocker Spaniel dog.
(TIF)
S2 Fig. Algorithm aimed at diagnosing Bernard-Soulier syndrome affected dogs using
ADVIA 2120, Siemens.
(TIF)
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S3 Fig. Western blot analysis in a healthy control dog and a Bernard-Soulier syndrome
affected dog.
(TIF)
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